Trial intelligence / Profile preview

Collagenase injection versus limited fasciectomy for moderate Dupuytren's contracture

2016-004251-76Phase 4Unknown

Sponsor
University Hospitals of Leicester NHS Trust
Start
Mar 2017
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of collagenase clostridium histolyticum in Dupuytren's contracture (2 arms), sponsored by University Hospitals of Leicester NHS Trust. Primary endpoint: Change in Patient Evaluation Measure. Status: unknown.

02

Drugs

collagenase clostridium histolyticum
03

Conditions

Dupuytren's contracture

Beyond the preview

Go deeper on 2016-004251-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-004251-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call